USDA expands biobased product push—with private industry funding the ads
H.R. 4832 — Biomanufacturing and Jobs Act of 2025 · Filed by Mark Alford (R-MO) · 7 cosponsors · Introduced Aug 1, 2025 · Referred to committee
Your members of Congress
Enter a ZIP to see where your representative and both senators stood on this bill.
Looked up on this device — your ZIP is never stored on our servers.
What it does
This bill expands the USDA's BioPreferred Program, which promotes biobased products (made from agricultural commodities like corn and soybeans) by requiring federal agencies to purchase more of them and establishing clearer labeling standards. It creates a task force to coordinate USDA research and marketing of biobased products, allows the USDA to accept private funding for promotional campaigns, and updates federal procurement systems to track biobased purchases. The bill benefits farmers and rural economies by creating new markets for agricultural feedstock, and benefits biomanufacturers by increasing federal demand and market visibility.
Why we flagged it
The bill's core mechanism is expanding federal procurement and labeling of biobased agricultural products to create new markets for farmers and rural manufacturers. While it benefits specific industries (biomanufacturers, agricultural commodity producers), the stated purpose—rural economic development and petroleum reduction—is genuine and publicly articulated.
What the text implies
- The bill allows the USDA to accept private (non-federal) funding for marketing biobased products without appropriation limits, potentially creating a public-private marketing apparatus where private biomanufacturers fund government promotion of their own products—blurring the line between public education and industry advertising.
- Federal procurement requirements may increase costs to agencies if biobased products carry price premiums; the bill allows agencies to exceed price thresholds but does not cap or fund the difference, potentially shifting budget pressure to other agency priorities.
- The task force's 4-year lifespan and broad mandate to 'maximize resources' toward biobased products may concentrate USDA research and development funding away from other agricultural priorities without explicit reallocation authority.
- Labeling prohibitions and confidentiality provisions (Section 6) restrict public disclosure of proprietary business information, potentially limiting transparency about which companies benefit from the label and procurement preferences.
Who it affects
Ordinary citizens benefit from expanded rural economic development, reduced petroleum dependence, and clearer product labeling that enables informed purchasing. The bill creates jobs in biomanufacturing and supports agricultural commodity markets without imposing direct costs on consumers or taxpayers—federal procurement shifts to biobased products rather than adding new spending.
Who stands to gain
- biomanufacturers and biobased product companies
- agricultural commodity producers (corn, soybean farmers)
- rural development contractors and suppliers
- companies producing biobased plastics and industrial materials
Named in the bill
USDA (Department of Agriculture), BioPreferred Program, Office of Federal Procurement Policy, General Services Administration (GSA), ASTM International, Farm Security and Rural Investment Act of 2002, Federal Procurement Data System, System for Award Management
Where it stands
7 cosponsors: 5 Republicans, 2 Democrats.
- Aug 1, 2025 — Introduced · Congress.gov: “Introduced in House”
- Aug 1, 2025 — Referred to House Committee on Oversight and Government Reform and House Committee on Agriculture · Congress.gov: “Referred to the Committee on Agriculture, and in addition to the Committee on Oversight and Government…”
Dates and quoted wording are Congress.gov's action record; the timeline shows status changes, not every procedural step.
Money around this bill
10 lobbying clients named this bill on 13 disclosure filings across 3 quarters, Dec 2025 to Jun 2026. Those filings disclosed $5,160,000 in lobbying spend. A filing names 6 bills on average, so that figure is what each filing reported, not a share belonging to this bill.
More lobbying clients named this bill than 91% of bills with at least one filing.
Mark Alford, the sponsor, reported $600,750 in PAC receipts in the 2026 cycle.
- American Chemistry Council — $2,570,000 on 1 filing
- Lyondell Chemical Company — $1,530,000 on 2 filings
- Covestro LLC — $300,000 on 1 filing
- Basf Corporation — $200,000 on 1 filing
- Corn Refiners Association — $180,000 on 1 filing
Lobbying Disclosure Act filings through Jul 20, 2026. A filing shows who paid to lobby on a bill it names, not what changed.
How this was measured
Analysis — Quorum's AI read the full bill text on Jul 2, 2026; transparency and hidden-provision scores are compared against the median of 16,222 analysed bills.
Status and sponsors — Congress.gov's bill record — actions, committee referrals and cosponsors — loaded nightly. The timeline shows status changes, not every procedural action.
Money — Senate Lobbying Disclosure Act filings whose specific-issue field names this bill for quarters ending Dec 2025 to Jun 2026. A filing's amount is reported whole beside the median number of bills a filing names; it is never divided across them. PAC receipts are FEC-reported contributions to the sponsor's candidate committee in the 2026 cycle.
As of — lobbying records through Jul 20, 2026 · page rendered 2026-10-20.
“USDA expands biobased product push—with private industry funding the ads” QuorumCivic. https://share.quorumcivic.app/bill/119/hr4832 Report an error
The week in bills
One email, Sunday: what Congress passed, what it changed, and who paid.
One link arrives to confirm the address. It is used for this email and nothing else, and every issue carries an unsubscribe link.